SCHEMBL21971000

SCHEMBL21971000

COc1cccc(N(C)C)c1C1N(C)c2ccccc2N1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.49
▸ PDGFRB P09619 1/20 0.44
▸ HTR1A P08908 4/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ DRD2 P14416 1/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ THPO P40225 1/20 0.37
▸ MTOR P42345 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ BRD4 O60885 1/20 0.36
▸ BRPF1 P55201 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21970634 0.85 LMNA (0.59) LMNAPDGFRBKDM4EMAPTDRD2
SCHEMBL21971004 0.85 PDGFRB (0.53) LMNAPDGFRBKDM4EMAPTTP53
SCHEMBL21971399 0.82 LMNA (0.47) LMNAPDGFRBHTR1AKDM4EMAPT
SCHEMBL21972251 0.81 LMNA (0.49) LMNAPDGFRBKDM4EMAPTBRD4
SCHEMBL21972266 0.81 LMNA (0.49) LMNAPDGFRBHTR1AKDM4EMAPT
SCHEMBL21972245 0.80 LMNA (0.53) LMNAHTR1AKDM4EMAPTDRD2
SCHEMBL21971408 0.80 PDGFRB (0.47) LMNAPDGFRBKDM4EMAPTTP53
SCHEMBL21972258 0.77 LMNA (0.46) LMNAPDGFRBKDM4EBRD4BRPF1
SCHEMBL20739825 0.77 LMNA (0.54) LMNAPDGFRBHTR1AKDM4EMAPT
SCHEMBL21971007 0.76 LMNA (0.49) LMNAPDGFRBHTR1AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046655-B2 Compound and method for producing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2021-06-29 — — US disclosed
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200140394-A1 NOVEL COMPOUND AND METHOD FOR PRODUCING SAME CBR3, NR2E3, NR5A2 LMNA 4733/4885PDGFRB 2517/4885HTR1A 1849/4885
US-11046655-B2 Compound and method for producing same CBR3, NR5A1, NR2E3 LMNA 4570/4885PDGFRB 2499/4885HTR1A 1703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback